View by type:
Articles (3148)
Governments urged to invest in healthcare systems despite global economic uncertainty
We need to urgently invest in healthcare systems to build resilience against future crises and the growing burden of disease, finds new research.
Long COVID stigma may encourage people to hide the condition
A UK survey found most long COVID sufferers have experienced discrimination, prejudice or shame related to the condition.
Universal flu vaccine could protect against future pandemics
Scientists have used mRNA technology to create a vaccine that can protect against 20 types of influenza.
Countries (77)
Documents (8902)
RFP: Measles & Rubella Post Campaign Coverage Surveys
Gavi Alliance seeks to hire an organisation with expertise in conducting field surveys in low-income countries to conduct the Post Campaign Coverage Survey following Measles or Measles-Rubella follow-up campaigns in 3-5 countries during a pilot period of 18-24 months.
RFP: Immutable Backup Solution for Ransomware protection
Gavi is looking to contract a highly qualified and experienced IT Services provider to implement an intelligent, immutable and recoverable backup solution as an additional layer of control against ransomware attacks.
RFP: Domestic Financing for Immunization in targeted provinces in DRC
Gavi Alliance is seeking support for DRC targeted provinces to increase their domestic financing for immunization service delivery with the aim to increase immunization coverage and reduce Zero Dose children through increased leadership at the provincial level on immunization services.
Donor profiles (109)
Other(640)
A New Era of Vaccine Manufacturing in Africa
One of the prominent issues exposed by the COVID-19 pandemic is the urgent need to further diversify global vaccine manufacturing, particularly with regards to Africa. With the political realities of nationalism, trade barriers, and the absence…
Taking Stock of Humanitarian Access to Pandemic Vaccines
COVAX was launched in 2020 with equity as its foundational principle, and fundamental to its design from the outset was a vision to address the most unpredictable and hardest to fill gaps in global COVID-19 vaccine access.
